Status:
RECRUITING
A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Lead Sponsor:
Centre Hospitalier de PAU
Conditions:
Malignant Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current man...
Detailed Description
Malignant hypertension is the most severe form of high blood pressure, fatal if left untreated. It has not disappeared, with an increasing incidence. Patients with the disease, mainly young (35 to 55 ...
Eligibility Criteria
Inclusion
- Malignant hypertension according to the classic definition (Severe hypertension, above 180/110 associated with severe hypertensive retinopathy)
- Severe hypertension (above 180/110) associated with acute damage of 3 target organ due to high blood pressure
Exclusion
- Age \< 18 years old
- Patients who cannot freely give their consent, or patients who refuse to participate
- Dialysis
Key Trial Info
Start Date :
September 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 20 2034
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03755726
Start Date
September 20 2019
End Date
September 20 2034
Last Update
September 27 2024
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
CH d'Annecy
Annecy, France
2
CH de la côte Basque
Bayonne, France, 64109
3
Avicenne APHP
Bobigny, France, 93009
4
CHU - Hôpital St André
Bordeaux, France, 33000